Nufarm's Seed Technologies Review Unlikely to Realize Full Potential -- Market Talk

Dow Jones

May 22, 2025

2309 GMT - Nufarm's decision to review its Seed Technologies business isn't likely to deliver a good result for shareholders, reckons Jefferies. Nufarm says all options are on the table for Seed Technologies in the UBS-led review. Nufarm has grappled with low fish-oil pricing in recent months, which led it to tell investors that it won't achieve a target of A$100 million of omega-3 revenue in FY 2025. Analyst Ramoun Lazar says the review "is likely to result in subscale outcomes for shareholders, given constrained near-term AquaTerra economics due to poor pricing and suboptimal production cost profile." Jefferies downgrades Nufarm to "underperform," from "hold," and cuts its price target by 55%, to A$1.96/share. Nufarm ended Wednesday at A$2.81. (david.winning@wsj.com; @dwinningWSJ)

(END) Dow Jones Newswires

May 21, 2025 19:09 ET (23:09 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2537957172"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2537957172\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2537957172?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-22 07:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537957172","market":"sg","top_or_hot":-1,"title":"Nufarm's Seed Technologies Review Unlikely to Realize Full Potential -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  2309 GMT - Nufarm's decision to review its Seed Technologies business isn't likely to deliver a good result for shareholders, reckons Jefferies. Nufarm says all options are on the table for Seed Technologies in the UBS-led review. Nufarm has grappled with low fish-oil pricing in recent months, which led it to tell investors that it won't achieve a target of A$100 million of omega-3 revenue in FY 2025. Analyst Ramoun Lazar says the review \"is likely to result in subscale outcomes for shareholders, given constrained near-term AquaTerra economics due to poor pricing and suboptimal production cost profile.\" Jefferies downgrades Nufarm to \"underperform,\" from \"hold,\" and cuts its price target by 55%, to A$1.96/share. Nufarm ended Wednesday at A$2.81. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 21, 2025 19:09 ET (23:09 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nufarm's Seed Technologies Review Unlikely to Realize Full Potential -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNufarm's Seed Technologies Review Unlikely to Realize Full Potential -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-05-22 07:09</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  2309 GMT - Nufarm's decision to review its Seed Technologies business isn't likely to deliver a good result for shareholders, reckons Jefferies. Nufarm says all options are on the table for Seed Technologies in the UBS-led review. Nufarm has grappled with low fish-oil pricing in recent months, which led it to tell investors that it won't achieve a target of A$100 million of omega-3 revenue in FY 2025. Analyst Ramoun Lazar says the review \"is likely to result in subscale outcomes for shareholders, given constrained near-term AquaTerra economics due to poor pricing and suboptimal production cost profile.\" Jefferies downgrades Nufarm to \"underperform,\" from \"hold,\" and cuts its price target by 55%, to A$1.96/share. Nufarm ended Wednesday at A$2.81. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 21, 2025 19:09 ET (23:09 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7020","symbol_name":"化肥与农用药剂","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2537957172","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537957172","pubTimestamp":1747868940,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"2309 GMT - Nufarm's decision to review its Seed Technologies business isn't likely to deliver a good result for shareholders, reckons Jefferies. Nufarm says all options are on the table for Seed Technologies in the UBS-led review. Nufarm has grappled with low fish-oil pricing in recent months, which led it to tell investors that it won't achieve a target of A$100 million of omega-3 revenue in FY 2025. Analyst Ramoun Lazar says the review \"is likely to result in subscale outcomes for shareholders, given constrained near-term AquaTerra economics due to poor pricing and suboptimal production cost profile.\" Jefferies downgrades Nufarm to \"underperform,\" from \"hold,\" and cuts its price target by 55%, to A$1.96/share. Nufarm ended Wednesday at A$2.81. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7020":"化肥与农用药剂","NUF.AU":"NUFARM LTD"},"translate_title":"Nufarm的种子技术审查不太可能实现全部潜力——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NUF.AU":0.9},"content_text":"2309 GMT - Nufarm's decision to review its Seed Technologies business isn't likely to deliver a good result for shareholders, reckons Jefferies. Nufarm says all options are on the table for Seed Technologies in the UBS-led review. Nufarm has grappled with low fish-oil pricing in recent months, which led it to tell investors that it won't achieve a target of A$100 million of omega-3 revenue in FY 2025. Analyst Ramoun Lazar says the review \"is likely to result in subscale outcomes for shareholders, given constrained near-term AquaTerra economics due to poor pricing and suboptimal production cost profile.\" Jefferies downgrades Nufarm to \"underperform,\" from \"hold,\" and cuts its price target by 55%, to A$1.96/share. Nufarm ended Wednesday at A$2.81. (david.winning@wsj.com; @dwinningWSJ) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 21, 2025 19:09 ET (23:09 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}